(Q37373002)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19155198%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

review article

1 reference

title

Molecular biology of androgen-independent prostate cancer: the role of the androgen receptor pathway (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19155198%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19155198%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

B Mellado

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19155198%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

J Codony

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19155198%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

L Visa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19155198%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

P Gascón

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19155198%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19155198%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Translational Oncology

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19155198%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19155198%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19155198%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

5-10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19155198%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12094-009-0304-3

20 January 2020

exact match

0 references

cites work

Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12094-009-0304-3

Wnt signaling and prostate cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12094-009-0304-3

Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancer.

21 January 2018

1 reference

12 December 2020

Molecular determinants of resistance to antiandrogen therapy

1 reference

12 December 2020

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer

1 reference

12 December 2020

Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer

1 reference

12 December 2020

Cross-talk between the androgen receptor and the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer

1 reference

12 December 2020

Gateways to clinical trials

1 reference

12 December 2020

Type 1 and type 2 5alpha-reductase expression in the development and progression of prostate cancer

1 reference

12 December 2020

Hsp90 as a therapeutic target in prostate cancer

1 reference

12 December 2020

Unfaithfulness and promiscuity of a mutant androgen receptor in a hormone-refractory prostate cancer.

1 reference

12 December 2020

CYP17 inhibition as a hormonal strategy for prostate cancer.

1 reference

12 December 2020

Androgen receptor coactivators and prostate cancer.

1 reference

12 December 2020

Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis

1 reference

12 December 2020

The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay

1 reference

12 December 2020

Mechanisms of androgen-refractory prostate cancer

1 reference

12 December 2020

Androgen-response elements in hormone-refractory prostate cancer: implications for treatment development

1 reference

12 December 2020

The contribution of different androgen receptor domains to receptor dimerization and signaling

1 reference

12 December 2020

Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation

1 reference

12 December 2020

Pleiotropic functional properties of androgen receptor mutants in prostate cancer.

1 reference

12 December 2020

Mutation of the androgen receptor causes oncogenic transformation of the prostate

1 reference

12 December 2020

Targeting the androgen receptor pathway in prostate cancer

1 reference

12 December 2020

Androgen receptor: role and novel therapeutic prospects in prostate cancer

1 reference

12 December 2020

Prostate cancer stem cells: a new target for therapy

1 reference

12 December 2020

Role of the TMPRSS2-ERG gene fusion in prostate cancer

1 reference

12 December 2020

The development of androgen-independent prostate cancer

1 reference

12 December 2020

Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.

1 reference

12 December 2020

Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.

1 reference

12 December 2020

Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex

1 reference

12 December 2020

Castration-recurrent prostate cancer is not androgen-independent

1 reference

12 December 2020

Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.

1 reference

12 December 2020

Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatment.

1 reference

12 December 2020

The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.

1 reference

12 December 2020

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

1 reference

12 December 2020

Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor.

1 reference

12 December 2020

Serum HER2 extracellular domain predicts an aggressive clinical outcome and biological PSA response in hormone-independent prostate cancer patients treated with docetaxel

1 reference

12 December 2020

Androgen receptor expression in prostate cancer stem cells: is there a conundrum?

1 reference

12 December 2020

Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth

1 reference

12 December 2020

Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growth.

1 reference

12 December 2020

Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer

1 reference

12 December 2020

10.1007/S12094-009-0304-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19155198%20AND%20SRC:MED&resulttype=core&format=json

release_te6laq465rgx5ju7rwmy2gj2dm

20 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/te6laq465rgx5ju7rwmy2gj2dm

24 November 2022

mapped directly with Wikidata item

1 reference